© Copyright 2023, All Rights Reserved by Banty (in partnership with BV Medical)
The study, called KALOS, is for people with asthma whose symptoms are not fully controlled using their current inhaler treatment.
The study will see whether a new type of inhaler called BGF MDI may provide benefit to people with this type of asthma. The findings from this study may help people diagnosed with asthma in the future.
Taking part is entirely voluntary. Participants can leave a study at any time and for any reason.
You may be able to join the study if you:
If you are interested in signing up to participate, Dr. Sidhu and her team staff will guide you through a screening process to see if you quality.